Spinal 2-Chloroprocaine: A Comparison with Lidocaine in Volunteers

Anesthesia and Analgesia

Volumn 98, Issue 1, 2004, Pages 75-80

  Kouri, Mary E ^a   Kopacz, Dan J ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROPROCAINE; LIDOCAINE; PRESERVATIVE;

ABDOMINAL PAIN; ADULT; AMBULATORY SURGERY; ANESTHESIA; ANESTHESIA LEVEL; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HEADACHE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; LOW BACK PAIN; MALE; MUSCLE STRENGTH; NERVE BLOCK; NEUROLOGIC DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; SPINAL ANESTHESIA; TOURNIQUET; TRANSCUTANEOUS NERVE STIMULATION; TRANSIENT NEUROLOGIC SYMPTOM; VISUAL ANALOG SCALE;

EID: 0346102662     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000093228.61443.EE     Document Type: Article

References (19)

1. Foldes FF, McNall PG. 2-chloroprocaine: a new local anesthetic agent. Anesthesiology 1952;13:287-96.
2. Winnie AP, Nader AM. Santayana's prophecy fulfilled. Reg Anesth Pain Med 2001;26:558-64.
3. Reisner LS, Lin D. Anesthesia for cesarean section. In: Chestnut D, ed. Obstetric anesthesia, principles and practice. St. Louis: Mosby, 1994:459-86.
4. Ravindran RS, Bond VK, Tasch MD, et al. Prolonged neural blockade following regional anesthesia with 2-chloroprocaine. Anesth Analg 1980;59:447-51.
5. Reisner LS, Hochman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg 1980;59:452-4.
6. Moore DC, Spierdijk J, van Kleef JD, et al. Chloroprocaine toxicity: four additional cases. Anesth Analg 1982;61:155-9.
7. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy. Reg Anesth 1984;9:124-45.
8. Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and Nesacaine-CE-an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984;63:445-7.
9. Schneider M, Ettlin T, Kaufman M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993;76:1154-7.
10. Pollock JE. Transient neurologic symptoms: etiology, risk factors, and management. Reg Anesth Pain Med 2002;27:581-6.
11. Smith KN, Kopacz DJ. Spinal 2-chloroprocaine: a dose ranging study and the effect of added epinephrine. Anesth Analg 2003;97:81-8.
12. Petersen-Felix S, Zbinden AM, Fischer M, et al. Isoflurane minimum alveolar concentration decreases during anesthesia and surgery. Anesthesiology 1993;79:959-65.
13. Hampl KF, Heinzmann-Wiedmer RA, Luginbuehl I, et al. Transient neurologic symptoms after spinal anesthesia; a lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology 1998;88:629-33.
14. Ben-David B, Levin H, Solomon E, et al. Spinal bupivacaine in ambulatory surgery: the effect of saline dilution. Anesth Analg 1996;83:716-20.
15. Liu SS, Ware PD, Allen HW, et al. Dose-response characteristics of spinal bupivacaine in volunteers. Anesthesiology 1996;85:729-36.
16. Hodgson PS, Lui SS, Batra MS, et al. Procaine compared with lidocaine for incidence of transient neurologic symptoms. Reg Anesth Pain Med 2000;25:218-22.
17. Truong HHL, Girard M, Drolet P. Spinal anesthesia: a comparison of procaine and lidocaine. Can J Anaesth 2001;48:470-3.
18. Bergeron L, Girard M, Drolet P. Spinal procaine with and without epinephrine and its relation to transient radicular irritation. Can J Anaesth 1999;46:846-9.
19. Stevens RA, Urmey WF, Urquhart BL, Kao T. Back pain after epidural anesthesia with chloroprocaine. Anesthesiology 1993;78:492-7.